Testing the Farapulse and Watchman devices together
Part of Heart & circulation clinical trials.
This trial is for people who need both a special heart treatment called pulsed field ablation (FARAPULSE) and a device to close off a small pouch in the heart (WATCHMAN FLX Pro or WATCHMAN FLX) to prevent strokes. The study will see how well both procedures work when done together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your doctor has decided you need both procedures: the FARAPULSE system to treat an abnormal heart rhythm and the WATCHMAN device to close a part of your heart.
- You are at least 18 years old and can give your own permission to be in the study.
- You can and will come to all the study visits and follow the study rules.
- You have not had any prior treatment for atrial fibrillation using a catheter-based procedure.
- You have not had a stroke or mini-stroke in the last 3 months.
- You are not pregnant and do not plan to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new system that maps and treats atrial fibrillation using special energy (pulsed field ablation) during a repeat ablation procedure. It also uses a small implanted monitor to track your heart rhythm before and after the procedure, which may help improve outcomes.
This trial tests a new device to help doctors safely enter the left side of your heart during a procedure called ablation. If you are already scheduled for an ablation or a combined ablation and left atrial appendage closure, this study may be an option.
This study tests a special catheter that uses pulsed field energy to ablate (destroy) the tiny areas in the heart causing irregular heartbeats. It is designed for people with paroxysmal atrial fibrillation (episodes that come and go) that hasn't been controlled by medication.
This trial tests a newer treatment called pulsed field ablation (PFA) for people with paroxysmal atrial fibrillation (AF), where the heart's rhythm is irregular and comes and goes on its own within 7 days. The goal is to see if PFA can restore a normal heart rhythm while better protecting the heart's left atrial function, which helps pump blood effectively. If you have AF and medications haven't worked, this could be an option to discuss with your doctor.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
This study tests if adding a special energy treatment (pulsed field ablation) to a standard heart pouch closure is safe and works better for people with persistent atrial fibrillation who have few symptoms but a high risk of stroke.
Hear when a new Stroke Prevention in Patients With Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.